2506
Z. Liu et al. / Bioorg. Med. Chem. Lett. 13 (2003) 2505–2507
The resin was filtered and washed completely with
DMF, AcOH/MeOH (1:10), MeOH, CH2Cl2. T he
newly formed resin in CHCl3 or EtOAc (20 mL) was
refluxed for 2 h. The resin was filtered and washed with
EtOH and acetone completely. The filtrates were com-
bined to afford the product by evaporation.17
In summary, we have developed an efficient, facile
method of solid phase synthesis of tetramic acid from
polymer supported cyclic malonic acid ester. This is a
traceless cyclative cleavage under mild conditions. The
N-protected tetramic acid was prepared with good yield
and high purity. Further work is in progress on the solid
phase synthesis of heterocyclic compounds via the resin-
bound cyclic malonic ester.
Scheme 1.
Acknowledgements
Table 1. Solid phase synthesis of tetramic acid
We are grateful to the National Nature Science Founda-
tion of China (Project 20072032) for financial support.
Entry Product
X
R
Yield Purity
(%)a
(%)b
1
2
3
4
5
6
7
8
9c
10
11
12
13
4a
4b
4c
4d
4e
4f
4g
4h
4a
4i
C6H5CO
4-CH3OC6H4 CO
4-CH3C6H4 CO
4-ClC6H4CO
COOCH2CH3
COOCH3
COOCH2C6H5
COCH3
H
H
H
H
H
H
H
H
H
92
90
78
67
88
78
76
90
92
80
84
81
88
>93
>90
>92
>90
>94
>91
>90
>95
>93
>95
>92
>90
>90
References and Notes
1. Royles, B. J. L. Chem. Rev. 1995, 95, 1981.
2. DeBoer, C.; Dietz, A.; Silver, W. S. Savage, G. M. In
Antibiotics Annual, Welch, H., Marti-Ibanez, J. Eds., Medical
Encyclopedia Inc. New York, 1956, p 886
C6H5CO
C6H5CO
Boc
Boc
CH3
Bui
C6H5CH2
CH3
3. Meyer, C. E. J. Antibiot. 1971, 24, 558.
4j
4k
4l
4. Tsukiura, H.; Tomita, K.; Hanada, M.; Kobaru, S.; Tsu-
nakawa, M.; Fujisawa, K.; Kawaguchi, H. J. Antibiot. 1980,
33, 157.
5. Sakuda, S.; Ono, M.; Ikeda, H.; Inagaki, Y.; Nakayama, J.;
Suzuki, A.; Isogal, A. Tetrahedron Lett. 1997, 38, 7399.
6. Hopmann, C.; Kurz, M.; Bronstrup, M.; Wink, J.; LeBel-
ler, D. Tetrahedron Lett. 2002, 43, 435.
Boc
aThe yield was based on the loading of resin 1.
bDetermined by 1H NMR (400 MHz).
cUsing the regenerated resin.
7. Rooney, C.; Randall, W.; Streeter, K.; Ziegler, C.; Cragos,
E., Jr.; Schwan, H.; Michelson, S.; Williams, H.; Eichler, E.;
Duggan, D.; Ulm, E.; Noll, R. J. Med. Chem. 1983, 26, 700.
8. For reviews about solid phase synthesis of heterocyclic
compound, see: (a) Franzen, R. G. J. Comb. Chem. 2000, 2,
195. (b) Nefzi, A.; Ostresh, J. M.; Houghten, R. A. Chem. Rev.
1997, 97, 449. (c) Thompson, L. A.; Ellman, J. A. Chem. Rev.
1996, 96, 555. (d) Krchnak, V.; Holladay, M. W. Chem. Rev.
2002, 102, 61.
9. Kulkarni, B. A.; Ganesan, A. Tetrahedron Lett. 1998, 39,
4369.
10. Matthews, J.; Rivero, R. A. J. Org. Chem. 1998, 63, 4808.
11. Romoff, T. T.; Ma, L.; Wang, Y. W.; Campell, D. A.
Synlett. 1998, 1341.
be recovered and reused to prepare the cyclic malonic
acid ester resin 1.15 The good result was also obtained
when the regenerated resin was used (Table 1, entry 9).
The synthesis of optically active tetramic acid is a
research field of major importance as it has relevance to
virtually all areas of pharmaceutical industries. The
development of such enantiomerically pure compounds
has gained increasing interest in organic and medicinal
16
chemistry. So we use an N-protected l-amino acid to
run this reaction. It was found that the reaction worked
very well and give the optically active compounds (4i–
4l) with good yield and high purity. The optical purity
of the amino acids is retained in the tetramic acids dur-
ing the synthesis.
12. (a) Hamilakis, S.; Kontonassios, D.; Sandris, C. J. Het-
erocyclic. Chem. 1996, 33, 825. (b) Hamilakis, S.; Konto-
nassios, D.; Sandris, C. J. Heterocyclic. Chem. 1996, 31, 1145.
(c) Li, B. Q.; Franck, R. D. Bioorg. Med. Chem. Lett. 1999, 9,
2629.
13. For reviews about Meldrum’s acid, see: (a) McNab, H.
Chem. Soc. Rev. 1978, 7, 345. (b) Chen, B. C. Heterocycles
1991, 32, 529. (c) Gaber Abd El-Aal, M.; McNab, H. Synth-
esis 2001, 2059.
14. (a) Huang, X.; Liu, Z. X. Tetrahedron Lett. 2001, 43,
7655. (b) Huang, X.; Liu, Z. X. J. Org. Chem. 2002, 67, 6731.
15. The loading of the regenerated cyclic malonic acid ester is
1.20 mmol/g which is determined by reversed titration with
hydrochloride acid after saponification with excess NaOH in
EtOH.
Typical Procedure for the Solid Phase Synthesis of
Tetramic Acid
To the suspension of cyclic malonic acid ester resin 1
(500 mg, 1.20 mmol/g) in CH2Cl2 (5 mL), N-protected
amino acid (3 mmol), DMAP (4.5 mmol, 0.55 g) were
added. Then the solution of DCC (3.6 mmol, 0.72 g) in
CH2Cl2 (5 mL) was added dropwise under nitrogen.
The mixture was stirred at room temperature for 10 h.